Michel André Chromik

This study shows that ex vivo supplementation of primary human macrophages with n-3 PUFAs increases phagocytosis, likely through reduced PGE2 levels rather than direct oxylipin effects.

This paper designs and tests sEH-PROTACs to degrade soluble epoxide hydrolase, identifying PROTAC 23 as effective in degrading sEH in human macrophages.

This study shows that LPS differentially affects phagocytosis in M1- and M2-like macrophages via PGE2 and EP4 signaling, with NSAID inhibition increasing phagocytosis in M1-like macrophages.